Artificial intelligence continues to revolutionize diverse aspects of biotechnology and medicine. Novel AI platforms accelerate drug discovery, enabling large-scale data generation and molecular design. Progress in AI-driven radiomics and ultramodern ultrasound techniques enhances cancer diagnosis and prognosis. Additionally, AI-powered tools improve clinical trial monitoring and healthcare administration. Cutting-edge studies on AI chatbots in mental health reveal both promising opportunities and ethical challenges, emphasizing the need for thoughtful integration of AI technologies across healthcare domains.